DR Horton Inc annual ebitda for fiscal TTM was $4.2 billion, a decrease of 12.6% from $4.8 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EBITDA (annual) | TTM → 2026-03-31 | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 | 2014-09-30 | 2013-09-30 | 2012-09-30 | 2011-09-30 | 2010-09-30 | 2009-09-30 | 2008-09-30 | 2007-09-30 | 2006-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA | $4.2B | $4.8B | $6.4B | $6.4B | $7.7B | $5.4B | $3.1B | $2.2B | $2.1B | $1.7B | $1.4B | $1.2B | $853M | $686M | $289M | $84M | $205M | ($429M) | ($2.5B) | ($863M) | $2.1B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EBITDA (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| EBITDA | $761M | $857M | $1.2B | $1.4B | $1.1B | $1.1B | $1.7B | $1.8B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More DHI metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow · Shares Outstanding
All DHI financial statements → Interactive DHI charts →
About TickerBase · Data methodology & sources